St. Jude Medical

An article about St. Jude Medical, a medical device company

St. Jude Medical logo

St. Jude Medical was a global medical device company headquartered in Little Canada, Minnesota, United States. The company was founded in 1976 and was a leading developer and manufacturer of cardiovascular medical devices. St. Jude Medical was acquired by Abbott Laboratories in January 2017.

History

St. Jude Medical was established in 1976 by Manuel A. Villafaña. The company initially focused on developing and manufacturing heart valves. Over the years, St. Jude Medical expanded its product line to include a wide range of medical devices for the treatment of cardiovascular diseases.

In 1994, St. Jude Medical acquired Pacesetter, Inc., a leading manufacturer of pacemakers and implantable cardioverter-defibrillators (ICDs). This acquisition significantly expanded the company's product offerings in the field of cardiac rhythm management.

Products

St. Jude Medical's product portfolio included devices for cardiac rhythm management, cardiovascular surgery, electrophysiology, and neuromodulation.

Cardiac Rhythm Management

The company was known for its innovative pacemakers and ICDs, which were used to treat patients with arrhythmias. These devices helped regulate the heart's rhythm and prevent sudden cardiac arrest.

Cardiovascular Surgery

St. Jude Medical developed a range of products for use in cardiovascular surgery, including mechanical and tissue heart valves, as well as products for coronary artery bypass grafting (CABG).

Electrophysiology

The company offered a variety of products for electrophysiology, including diagnostic and therapeutic catheters used in the treatment of atrial fibrillation and other cardiac arrhythmias.

Neuromodulation

St. Jude Medical also developed devices for neuromodulation, which were used to treat chronic pain and movement disorders. These devices delivered electrical stimulation to specific areas of the nervous system.

Acquisition by Abbott

In January 2017, St. Jude Medical was acquired by Abbott Laboratories for approximately $25 billion. This acquisition allowed Abbott to expand its portfolio of cardiovascular and neuromodulation products, enhancing its position in the global medical device market.

Related pages

• Abbott Laboratories
• Cardiac rhythm management
• Heart valve
• Pacemaker
• Implantable cardioverter-defibrillator